메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States

The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the same conditions as the reference product ACTEMRA® (tocilizumab) AVTOZMA is Celltrion's fifth immunology biologic and seventh biosimilar approved by the FDA This launch strengthens Celltrion's immunology portfolio beyond tumor-necrosis factor (TNF)-alpha and interleukin (IL)-12 and 23 inhibitors, to include an IL-6 inhibitor, broadening coverage across multiple inflammatory pathways and addressing a wider spectrum of diseases and patient populations I
- 김갑성 기자
- 2025-10-02 20:30
AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing

[ 메디채널 김갑성 기자 ] Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional medicine with state-of-the-art technologies. Patented Flagship NB-A002 is a First-in-class DNA Damage Response ("DDR") therapeutic product candidate, targeting the previously undruggable target ILF2, inducing synthetic lethality in DDR and Homologous Recombination Deficiency Cancers. Patented Drug-Target Interaction Graph Neural Network (&qu
- 김갑성 기자
- 2025-10-02 19:50
CMEF 2025: 의료 생태계에도 스며든 혁신의 바람

[ 메디채널 김갑성 기자 ] 광저우, 중국 2025년 10월 2일 -- 리드 시노팜 엑시비션즈(Reed Sinopharm Exhibitions)가 주최하는 제92회 중국 국제 의료기기 박람회(CMEF 2025) 추계 전시회가 9월 26일부터 29일까지 광저우 캔톤 페어 콤플렉스(Canton Fair Complex)에서 진행됐다. 약 16만 제곱미터 면적에서 진행된 이 행사에는 20개 국가 및 지역 3천여개 업체가 신제품 1만여 점을 전시했으며, 160여개 국가에서 방문객 12만 명의 눈길을 사로잡았다. 의료 혁신과 고품질 개발을 선도하는 허브라는 CMEF의 지위가 다시 한번 확인되는 순간이었다. CMEF는 지난 40년 동안 제품 출시, 기술 교류, 조달, 학술 협력, 브랜드 구축을 망라하는 최고의 플랫폼으로 등극했다. 올해는 의료 영상, 체외 진단, 수술 로봇, 스마트 헬스케어 등 28개 테마 구역으로 구성되어 연구 개발부터 실제 적용까지 공급망 전체가 주목을 받았다. 전시회 하이라이트 의료 영상 구역: 국산 디지털 심장 단일광자 단층촬영(SPECT)과 대형 평판형 이동식 C-arm 등 '이미징 펄스-
- 김갑성 기자
- 2025-10-02 17:56
Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson's Disease and Movement Disorders® 2025

[ 메디채널 김갑성 기자 ] Details of the Phase 3 MASCOT trial investigating amlenetug for the treatment of patients with Multiple System Atrophy (MSA) will be presented at the International Congress of Parkinson's Disease and Movement Disorders® 20251-3 MSA is a rare, rapidly progressing, neurodegenerative disease with no approved treatments available4,5 The innovative design of the pivotal MASCOT trial aims to accelerate drug development for patients living with MSA1 Amlenetug has previously received Orphan Drug Designation (ODD) from the US FDA and the EMA in Europe, in addition to SAKIGAK
- 김갑성 기자
- 2025-10-02 16:41
ExQor Technologies Announces Advancement Toward Clinical Trials for Brain Regenerative Medicine Platform to Treat Alzheimer's Disease

BOSTON, Oct. 2, 2025 -- Addressing Critical Unmet Medical Need ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine platform targeting Alzheimer's disease. Current Alzheimer's therapeutics are limited to slowing cognitive decline, but the company's preclinical data demonstrates something fundamentally different – the ability to reverse brain damage and promote regeneration. An additional trial is planned for frontotemporal dementia, while exploring other conditions affecting cognitive functi
- 김갑성 기자
- 2025-10-02 14:13
World Gym Corporation Advances Global Growth with Mexico MFA and Australia Expansion

Master Franchise Agreement to Bring Minimum of 30 Locations to Mexico; Company Adds Five New Locations Across Australia TAIPEI, Oct. 2, 2025 -- World Gym Corporation (2762.TW) ("World Gym" or the "Company"), the owner of the iconic World Gym brand with over 270 locations worldwide, today announced significant progress in its global growth initiatives, highlighted by a Master Franchise Agreement (MFA) in Mexico and surging growth across Australia. The MFA will bring a minimum of 30 new World Gym facilities to Mexico while the Company has added five new locat
- 김갑성 기자
- 2025-10-02 08:30
Kolmar Korea Presents "K-Beauty Success Roadmap" in Amazon Beauty in Seoul

Official manufacturing sponsor of Amazon Beauty in Seoul 2025, attracting over 3,000 online and offline participants Vice Chairman Sang-Hyun Yoon emphasizes the evolution toward blockbuster products as the key driver of K-Beauty's global success SEOUL, South Korea, Oct. 1, 2025 -- Kolmar Korea, a leading global ODM(Original Development Manufacturing) company, joined forces with Amazon to present a strategic roadmap for the worldwide expansion of K-Beauty. The company underscored that differentiated competitiveness built on technological expertise is the central element o
- 김갑성 기자
- 2025-10-01 22:12
Vatech Launches 'Boundless Campaign' to Eliminate Barriers in Dental Care

First milestone: reduced device operation time update eases discomfort for elderly and disabled patients SEOUL, South Korea, Oct. 1, 2025 -- Vatech (KOSDAQ: 043150), a global leader in dental imaging solutions, today announced the launch of its 'Boundless Campaign' a long-term initiative aimed at creating a world where no one is excluded from dental care. The campaign integrates technology innovation and corporate social responsibility (CSR), addressing challenges faced by patients who struggle to access dental services—including elderly patients with mobil
- 김갑성 기자
- 2025-10-01 21:00
Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India

HYDERABAD, India, Oct. 1, 2025 -- Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and Laboratory Sciences), a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad. This collaboration aims to bring high-value, next-generation sequencing (NGS) technologies closer to patients and healthcare providers across the country. By combining AMPATH's extensive diagnostic network with Gene Solutions' expertise in genomics, the partnership will enable more timely,
- 김갑성 기자
- 2025-10-01 20:01
CMEF 2025: Innovation Drives Global Synergy in Healthcare Ecosystem

GUANGZHOU, China, Oct. 1, 2025 -- The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition, organized by Reed Sinopharm Exhibitions, was held from September 26–29 at the Canton Fair Complex in Guangzhou. Covering nearly 160,000 square meters, the event gathered 3,000+ exhibitors from 20 countries and regions, presenting 10,000+ new products to 120,000 professional visitors from over 160 countries. CMEF reaffirmed its role as a globally influential hub for healthcare innovation and high-quality development. Over four decades, CMEF has evolved into a prem
- 김갑성 기자
- 2025-10-01 20:00

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-10-19_SUN

2025-10-18_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 19일 03시 20분